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Because it has been shown that high doses of propranolol
(40 to 80 mg orally, four times daily) markedly attenuate
cardiovascular response to exercise training in healthy
subjects, the effects of lower doses of this nonselective
beta-adrenergic receptor antagonist on the conditioning
response were investigated. Twelve normal men under-
went maximal treadmill testing before and after a 6 week
intensive exercise program. After an initial test, six men
were randomized in a paired fashion to receive low dose
propranolol and the others received no drug. The av-
erage propranolol dose ± standard error was 22 ± 4
mg four times daily, and the average decrease in max-
imal heart rate due to propranolol was 32 ± 4 beats/
min. Both groups trained at comparable intensities. At
the end of the training period, propranolol was stopped
Previous work by our group (l) has demonstrated that high
grade, nonselective blockade of beta-adrenergic receptors
in normal men results in a markedly attenuated response to
aerobic conditioning. This finding may have implications
for many conditioning programs for prevention or therapy
of cardiac disease, because use of beta-adrenergic receptor
blocking drugs is quite common.
Many individuals undergoing exercise training may be
taking less than maximal doses of beta-adrenergic receptor
blocking drugs. Accordingly, we have extended our studies
to normal subjects exposed to low levels of nonselective
receptor blockade. We have evaluated the effects of sub-
maximal blockade on aerobic conditioning and compared
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and testing was repeated so that the effect of beta-re-
ceptor blockade was no longer present but the training
effects still persisted. Maximal oxygen consumption in-
creased in control subjects from 47.5 ± 1.1 to 51.4 ±
0.4 ml/kg per min (p < 0.05) but was unchanged in those
receiving propranolol (47.2 ± 1.9 versus 47.4 ± 1.5).
Exercise duration increased in both groups but the in-
crement was greater in the control group (+2.4 versus
+1.1 min, p < 0.05).
It is concluded that low level beta-receptor blockade
attenuates cardiovascular conditioning in normal sub-
jects in exercise training programs. High levels of sym-
pathetic stimulation during training appear to be im-
portant, if not essential, to the conditioning process.
the training response to our previous results in studies that
utilized maximal beta-adrenergic receptor blockade. Twelve
healthy, sedentary, male volunteers were studied before,
during and after an intensive 6 week, aerobic exercise pro-
gram. Six subjects received no therapy and six received 20
to 30 mg of propranolol, four times daily, a dose designed
to afford partial beta-blockade. Effects of the conditioning
program were compared in the two groups by evaluating
treadmill performance when no drug effect was present be-
fore and after training.
Methods
Study group. Twelve male volunteers, aged 22 to 34
years, were recruited to participate in the study. None had
a history of cardiac or pulmonary disease or hypertension.
All were nonsmokers and had not exercised regularly for at
least 6 months before the study. The men had no evidence
of cardiovascular or pulmonary disease by physical exam-
ination. No attempt was made to blind either ourselves or
the participant, because in our prior study (l) in which we
did attempt double blinding, it was obvious to investigators
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and most participants whether the subjects were taking
medication.
Exercise protocol. Treadmill exercise testing was car-
ried out after the subjects had abstained from alcohol for at
least 72 hours and were in a fasting state for at least 12
hours. A supine electrocardiogram, heart rate (average of
10 recorded beats) and blood pressure were recorded after
a 10 minute rest period. Graded maximal treadmill testing
was then performed on a Quinton treadmill, model 1849C,
using 2 minute stages. The protocol was designed so that
the estimated total oxygen consumption was increased by
7 mllkg per min at each of the first three stages, and by 3.5
mllkg per min in each stage thereafter. Exercise was con-
tinued to exhaustion. The telemetered electrocardiogram was
continuously monitored on an oscilloscope. Blood pressure
by cuff sphygmomanometry, heart rate and electrocardio-
gram were recorded during the last 10 seconds of each
minute of exercise, and for 5 minutes after exercise.
Expired gases were collected using a Collins 13 liter
mouthpiece fitted to a Koegel valve. To measure ventilation,
expired air was directed through a hot-wire anemometer into
a mixing chamber. Expired carbon dioxide (C02) and ox-
ygen (02) were measured by continuous sampling from the
mixing chamber, using a Beckman LB-2 CO2 analyzer and
a fuel cell O2 analyzer. Outputs from these analyzers were
monitored on-line by a Micronova computer (Data General
Corporation). Every 30 seconds during exercise, printouts
were obtained of minute ventilation, oxygen consumption
and carbon dioxide production.
Propranolol protocol. After a preliminary screening
exercise test to assess suitability for inclusion in the study,
each subject underwent a control treadmill test before ex-
ercise training or drug administration was begun (Test I).
After Test I, participants were paired according to maximal
oxygen consumption and randomly (coin toss) assigned to
the control or drug group. The group randomized to receive
the propranolol therapy were given sufficient doses of the
drug to produce submaximal blockade. In our previous work
in normal men (1), high grade beta-adrenergic receptor
blockade with plasma levels in excess of 100 ng/ml resulted
in decreases in maximal exercise heart rate of 59 ± 3 beats/
min. We attempted to attain 50% submaximal beta-block-
ade, defined as a decrease of 30 beats/min in the maximal
exercise heart rate attained by subjects during Test I. We
initially gave propranolol (20 mg every 6 hours) to six
subjects. The dosage was increased, if necessary, to attain
a reduction of 30 beats/min in maximal heart rate on tread-
mill testing during the subsequent week. Before the tread-
mill test performed for dosage adjustment, blood samples
were drawn for measurement of the plasma concentration
of propranolol using the method of Aarons et al. (2). After
dosage adjustment, a second set of measurements during
treadmill exercise was performed (Test II). Both groups then
began a 6 week program of high intensity exercise condi-
tioning involving both supervised and unsupervised sessions.
Exercise training. Supervised sessions were held three
times per week and utilized telemetry monitoring. Each
session began with 5 minutes of stretching and warm-up
exercises. This was followed by 8 minutes of continuous
exercise on each of three devices: motor-driven treadmill,
bicycle ergometer and steps (repeated step-ups utilizing a
single step of fixed height). One or two minutes of rest was
allowed between the different modes of exercise. Average
steady state heart rate was recorded for each mode of ex-
ercise. A 20 minute run was undertaken after exercise on
the devices. Unsupervised sessions were scheduled on 2
additional days per week, with subjects monitoring and re-
porting their own steady state pulse rate during 30 to 40
minutes of continuous running or bicycling. Compliance
with medication was documented by weekly pill counts and
by a propranolol blood level obtained randomly, 6 hours
after a dose during the training. All subjects were required
to exercise at or above a minimal heart rate that was 75%
of the maximal heart rate attained during treadmill exercise
at Test I for the control group or Test II for the drug group.
The actual physical work performed was essentially iden-
tical for each pair of subjects whether in the control or
propranolol group.
At the end of the sixth week of training, a third treadmill
test (Test III) was performed in the drug group without
interrupting their training schedule. After this test, no further
drugs were administered and both the drug and control groups
continued to exercise for 3 days while residual stores of the
drug were metabolized. Both groups then underwent final
treadmill testing (Test IV).
Statistical analysis. Comparisons of the mean changes
within the control group were done by Student's t test for
paired data. Changes within the drug group were assessed
by two-way analysis of variance using the Student-Newman-
Keul's test for multiple comparisons with a probability [p]
value less than 0.05 considered to be significant. Compar-
ison of the mean difference between the placebo and pro-
pranolol groups was accomplished by an unpaired, two-
tailed t test. Results are reported as mean values ± standard
error.
Results
Description of subjects on entry. Table I compares the
control and drug groups on entry into the study. No sig-
nificant differences were found between the groups with
respect to age, weight, initial maximal oxygen consumption
or treadmill exercise duration.
Achievement of submaximal beta-blockade. Five of
six subjects initially received 20 mg of propranolol every 6
hours, and remained at that dose during the exercise period.
One subject's dose was increased to 30 mg every 6 hours
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Values are mean ± standard error. Differences between the groups
are not significant. \'02 max = maximal oxygen consumption.
Table 1. Comparison of Control and Propranolol Groups at
Entry Into Study
to attain the desired decrease in maximal exercise heart rate.
The mean decrease in maximal exercise heart rate during
submaximal beta-blockade was 32 ± 4 beats/min.
Compliance with medication and training. Compli-
ance with the prescribed dosage schedule was confirmed by
weekly counts of pill supplies, by observation of heart rates
attained during exercise and by measured blood levels of
propranolol. Table 2 lists the measured plasma trough levels
in the drug group obtained before Tests II and Ill. A spot-
check plasma level was also randomly obtained during the
training period and agreed with the other levels.
Compliance with the exercise protocol was excellent in
both the control and drug groups, with each group partic-
ipating in 92% of all prescribed training sessions. Intensity
of the training was similar and not statistically different for
both groups, with steady state maximal heart rates during
the monitored sessions at 85 ± 1% (165 ± 4 beats/min)
of maximal heart rate for the control group and 86 ± 1%
(139 ± 4 beats/min) for the drug group.
Side effects of drug treatment. Of the six subjects tak-
ing propranolol, one noted excessive fatigue during exer-
cise. This symptom gradually dissipated during the 6 week
training period. No other side effects were reported.
Effects of training in the control group. Comparison
of maximal treadmill performance before and after training
in the control group (Tests I and IV) demonstrated a mean
increase in maximal oxygen consumption from 47.5 ± 1.1
Age (yr)
Weight (kg)
\'02 max (ml/kg per min)
Exercise duration (min)
Control
25.4 ± 1.3
77.5 ± 7.6
47.5 ± 1.1
18.3 ± 0.7
Propranolol
26 I ± 1.2
79.8 ± 4.7
47.2 ± 1.9
179±08
Control Propranolol
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Figure 1. Effect of exercise training on maximal oxygen con-
sumption (\10 2 max). Brackets represent mean ± standard error.
I = exercise test before training or drug; II = test during drug
administration before training; III = test during drug administra-
tion after training; IV = test without drug after training.
to 51.4 ± 0.4 mllkg per min (p < 0.05) (Fig. 1 and 2).
Exercise duration increased from 18.3 ± 0.7 to 20.7 ±
0.7 minutes (p < O.OJ) (Fig. 3 and 4). Mean heart rate at
rest decreased from 68 ± 5 to 59 ± 3 beats/min, but this
change was not statistically significant (p < 0.09) (Fig. 5q,
Maximal exercise heart rate did not change after training.
Submaximal heart rate at work loads of 7 METS de-
creased from 134 ± 4 to 119 ± 3 beats/min (p < 0.02,
Fig. 5D). Rest systolic and diastolic pressures tended to
decrease, but changes were not statistically significant. Some
subjects increased their maximal ventilation, but there was
not a statistically significant change in this measurement.
No significant changes or trends were observed in maximal
systolic or diastolic pressure.
Effects of beta-adrenergic blockade before training.
After beta-blockade was achieved and before training com-
menced (Tests 1 and 11), there were significant decreases in
mean rest heart rate (70 ± 4 to 57 ± 2 beats/min, p <
0.05), maximal heart rate (194 ± 3 to 161 ± 4 beats/min,
Table 2. Effect of Submaximal Beta-Receptor Blockade on
Reduction of Maximal Exercise Heart Rate Before and After
Training
Figure 2. Intersubject variability of maximum oxygen consump-
tion (\10 2 max). Abbreviations as in Figure I.
* Corresponding steady state plasma trough levels obtained before
treadmill testing are listed along with dosing interval.
Values are mean ± standard error. Differences between groups are
not Significant.
Decrease in maximal
exercise heart rate
(beats/min)
Plasma level of propranolol
(ng/ml)*
Time interval between dose
and sample (h)
Test II
32 ± 4
16.5 ± 4.6
63 ± 0.4
Test III
24 ± 5
17.8 ± 4.9
6.2 ± 0.3
Control Propranolol
56
54 <,~ 52
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Figure 3. Effect of exercise training on treadmill exercise dura-
tion. Brackets represent mean :±: standard error. Abbreviations
as in Figure 1.
p < 0.05) and exercise duration (17.9 ± 0.8 to 16.0 ±
0.6 min, p < 0.05). Maximal systolic pressure tended to
decrease (200 ± 4 to 183 ± 6 mm Hg), but this decrease
was not statistically significant. No significant changes or
trends were observed in maximal oxygen consumption,
maximal ventilation, maximal diastolic pressure, rest dia-
stolic pressure or rest systolic pressure.
Effects of training in the propranolol group. Compari-
son of Tests I and IV in the drug group demonstrate the
effect of training when the subjects were tested in the ab-
sence of beta-adrenergic blockade, first on entry into the
study and then at the conclusion of the study after admin-
istration of the drug had been stopped. Maximal oxygen
consumption did not change from Test I to Test IV (Fig. 1
and 2). No significant difference in maximal oxygen con-
sumption was observed between the control and drug groups
before training, but a difference was observed between these
groups after training (51.4 ± 0.4 ml/kg per min for control
subjects versus 47.4 ± 1.5 ml/kg per min for the propran-
olol group, p < 0.05) (Fig. SA). Exercise duration in the
drug group increased slightly (17.9 ± 0.8 to 19.0 ± 0.6
min, p < 0.05) (Fig. 3 and 4). However, a significant
difference ( + 2.3 ± 0.2 min control versus + 1.1 ± 0.3
min propranolol, p < 0.01) was observed between the two
groups after training (Fig. 5B). A significant decrease was
observed in mean heart rate at rest (70 ± 4 to 62 ± 2 beats/
Figure 4. Intersubject variability of exercise duration. Abbrevi-
ations as in Figure 1.
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min, p < 0.05) (Fig. 5C) in the propranolol group, a de-
crease of 13%. However, submaximal heart rate at 7 METS
did not change after training (p = 0.51) (Fig. 5D). A sig-
nificant difference was observed in submaximal exercise
heart rate between the control and drug groups ( - 14 ± 4
versus - 3 ± 3 beats/min, respectively, p < 0.05). No
changes were observed in maximal heart rate, maximal di-
astolic pressure or maximal systolic pressure in the drug
group or between control and drug groups.
A comparison of Tests II and III shows the effect of
training in the presence of submaximal blockade. Exercise
duration increased with training (16.0 ± 0.6 to 18.1 ± 0.5
min, p < 0.05) (Fig. 3), but no significant changes were
observed in maximal oxygen consumption, maximal ven-
tilation, mean rest heart rate, maximal heart rate or sub-
maximal heart rate.
The effect of submaximal beta-blockade on exercise per-
formance after training is demonstrated by comparing Tests
III and IV in the drug group. Maximal heart rate increased
from 168 ± 5 to 191 ± 3 beats/min (p < 0.05). Mean heart
rate at rest was 56 ± 4 beats/min in Test III and 62 ± 2
beats/min in Test IV (p = not significant). Exercise duration
improved significantly from 18.1 ± 0.5 to 19.0 ± 0.6 min
(p < 0.05) (Fig. 3). Maximal ventilation tended to improve
(124.0 ± 7.5 to 136.2 ± 6.5 liters/min), but the increase
was not significant. No significant changes were noted in
maximal oxygen consumption, maximal diastolic pressure,
rest systolic pressure or rest diastolic pressure.
Discussion
We have shown that low dose beta-adrenergic receptor
blockade markedly attenuates the training response to aero-
bic conditioning in healthy men, as evidenced by lack of
improvement in maximal oxygen consumption, relatively
small improvement in duration of exercise and lack of change
in submaximal exercise heart rate. In contrast, the control
group demonstrated an increase in maximal oxygen con-
sumption, a larger increase in exercise duration and a sig-
nificant decrease in submaximal exercise heart rate.
On comparison of these results with those obtained in
our previous study (1) utilizing high dose beta-adrenergic
blockade and a similar training regimen (Fig. 6), the only
difference between the two treatment groups was a decrease
in rest heart rate seen in the group with submaximal beta-
blockade. Thus, the group with submaximal beta-blockade
had essentially the same attenuated response as did the group
with maximal blockade.
Effect of propranolol on exercise training response.
Our findings demonstrate that beta-blockade (whether high
or low dose) inhibits the training response to aerobic exercise
conditioning in normal persons. It has been established that
the intensity (that is, in terms of heart rate) of a training
program is a major factor that governs the observed training
JACC Vol. 2, No 3
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Figure 5. Comparison of the effects of exercise
training in the control and propranolol groups.
Brackets represent mean ± standard error. Before
training there were no significant differences for any
of the variables. Significant differences between the
groups after training are indicated by the p values.
Comparison was done by the unpaired two-tailed t
test. HR = heart rate; NS = not significant; p =
probability; submax = submaximal heart rate at
work loads of 7 METS; \10 2 max = maximal ox-
ygen consumption.
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response (3). Karvonen (4) stated that a target heart rate of
at least 60% of the difference between maximal heart rate
and rest heart rate is necessary before a training response
is observed in a training program of at least 4 to 5 days per
week.
Patients receiving propranolol exercised at less than 60%
of this difference while taking the drug. Thus, heart rates
during training in the propranolol group were lower than
those generally required for training to occur in a typical
exercise regimen in unmedicated, normal subjects. A pos-
sible reason for the poor training response in our subjects
who were taking propranolol was their inability to attain a
high enough heart rate during training because of beta-ad-
renergic receptor blockade. The mechanisms by which con-
ditioning occurs are unknown, but the effect of a high ex-
ercise training heart rate would be expected to be a high
myocardial oxygen consumption, which may be necessary
for cardiac conditioning to occur. Because propranolol pre-
vented a high heart rate during training, it may not have
allowed a sufficient increase in myocardial oxygen con-
sumption for cardiac training effects. The small increases
in exercise duration after training that were unaccompanied
by increases in myocardial oxygen consumption in the pro-
pranolol group may reflect some degree of conditioning of
skeletal muscle or the peripheral circulation without central
cardiac conditioning.
Clinical implications. The findingsof these studiesshould
be interpreted only in the context of normal persons without
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Figure 6. Comparison of the effects of submaximal
(50%) and maximal beta-blockade on the training re-
sponse to aerobic conditioning. Data for maximal
blockade from Sable et al. (I). Brackets represent
mean ± standard error. Max = group with maximal
beta-receptor blockade; submax = group with sub-
maximal beta-receptor blockade. Other abbreviations
as in Figure 5.
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evidence of corollary artery disease. In a recent study (5),
it was concluded that conditioning does occur in patients
with coronary artery disease who are under the influence of
beta-adrenergic blockade. Ifthis is confirmed, consideration
must be given to the possibility that the mechanisms gov-
erning the training response in normal persons and those
with coronary disease may be different. It would appear
from our two studies that the sympathetic nervous system
must be intact to produce a training effect in normal persons.
In patients with coronary artery disease, myocardial isch-
emia during exercise may prevent conditioning whether or
not beta-blockade is present. Noncardiac effects of training
ing may be a major aspect of conditioning in patients with
coronary artery disease, and these may be unaffected by
beta-blockade.
The lack of training effect in normal subjects taking beta-
adrenergic receptor blocking agents may be of clinical sig-
nificance, regardless of effects of these drugs in patients
with coronary artery disease. Many persons without coro-
nary disease may continue taking beta-adrenergic receptor
blocking agents and undergo exercise training as part of
preventive health programs. These would include subjects
with arrhythmias or hypertension, which are common in the
absence of coronary disease. Ifour results in normal subjects
can be extrapolated to such persons, they may not gain the
usual cardiovascular conditioning effects with standard ex-
ercise regimens.
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